Nectar Lifesciences Limited has informed regarding Disclosure of material issue w.r.t.: 1. Transfer of the active pharmaceutical ingredients and formulations Business on a 'slump sale' basis; 2. Sale, transfer and delivery of Menthol Assets.3. Date of EGM